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 Abstract 20 
Background: Uropathogenic Escherichia coli (UPEC) are a frequent cause of catheter 21 
associated urinary tract infection (CAUTI). Biocides have been incorporated into catheter-22 
coatings to inhibit bacterial colonisation whilst ideally exhibiting low cytotoxicity and 23 
mitigating the selection of resistant bacterial populations. We compared the effects of long-24 
term biocide exposure on susceptibility, biofilm-formation and relative-pathogenicity in eight 25 
UPEC isolates. Methods: Minimum inhibitory concentrations (MIC), minimum bactericidal 26 
concentrations (MBC), minimum biofilm eradication concentrations (MBEC) and antibiotic 27 
susceptibilities were determined before and after long-term exposure to triclosan, 28 
polyhexamethylene biguanide (PHMB), benzalkonium chloride (BAC) and silver nitrate. 29 
Biofilm-formation was quantified using a crystal violet assay and relative-pathogenicity was 30 
assessed via a Galleria mellonella waxworm model. Cytotoxicity and resulting 31 
biocompatability index values were determined against an L929 murine fibroblast cell line. 32 
Results: Biocide exposure resulted in multiple decreases in biocide susceptibility in 33 
planktonic and biofilm associated UPEC. Triclosan exposure induced the largest frequency 34 
and magnitude of susceptibility decreases at MIC, MBC and MBEC, which correlated to an 35 
increase in biofilm biomass in all isolates. Induction of antibiotic-cross-resistance occurred in 36 
6/84 possible combinations of bacteria, biocide and antibiotic. Relative-pathogenicity 37 
significantly decreased after triclosan exposure (5/8 isolates), increased after silver nitrate 38 
exposure (2/8 isolates) and varied between isolates for PHMB and BAC. Biocompatibility 39 
index ranked antiseptic potential as PHMB>triclosan>BAC>silver nitrate. Conclusion: 40 
Biocide exposure in UPEC may lead to reductions in biocide and antibiotic susceptibility, 41 
changes in biofilm-formation and alterations relative-pathogenicity. These data indicate the 42 
multiple consequences of biocide adaptation that should be considered when selecting an 43 
anti-infective catheter-coating agent.44 
45 
46 
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 Introduction 47 
Catheter-associated urinary tract infections (CAUTI) are amongst the most commonly 48 
acquired healthcare associated infections contributing considerably to patient morbidity and 49 
posing an economic burden on healthcare service providers (1). Complications associated 50 
with catheterisation often arise due to contamination of the catheter surface with 51 
uropathogenic Escherichia coli (UPEC) during catheter insertion, leading to the formation of 52 
bacterial biofilms and subsequent infection. Patients undergoing long-term catheterisation are 53 
at a particular risk of acquiring CAUTI, with studies indicating a 5-8% increase in the risk of 54 
developing bacteriuria for every day that the catheter remains inserted (2). The majority of 55 
patients will exhibit bacteriuria after four weeks of catheterisation, potentially leading to 56 
further complications such as pyelonephritis and septicaemia (2, 3). 57 
Bacterial biofilms are often recalcitrant to antimicrobial chemotherapy and to the actions of 58 
the host immune system, making biofilm associated infections such as CAUTIs difficult to 59 
treat (4). Biofilms show decreased susceptibility to antibiotics, partially due to the shielding 60 
effect of the extracellular polymeric substance (EPS) encasing the bacterial cells (5), the low 61 
metabolic activity of the cells within the biofilm (6) and the activity of membrane-bound 62 
efflux pumps that actively expel antimicrobial compounds from the bacterial cell (4). 63 
Furthermore, antibiotic-resistance genes are frequently transferred between bacteria within a 64 
biofilm by horizontal gene transfer allowing the dissemination of resistance through a 65 
bacterial population (7). Antibiotic treatment of CAUTIs is therefore often ineffective due to 66 
the recalcitrance of the biofilm in addition to the increasing prevalence of antibiotic resistant 67 
uropathogens (8). There is considerable interest in developing anti-infective catheter coatings 68 
that are refractory to microbial colonisation and subsequent biofilm formation in an attempt 69 
to prevent the establishment of CAUTI.  70 
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 Biocides are broad-spectrum antimicrobial chemicals that inhibit the growth of, or kill 71 
microorganisms (9). Biocide coated urinary catheters have been developed incorporating 72 
biocides such as silver nitrate and nitrofurazone that are eluted from the surface of the 73 
catheter providing an antimicrobial gradient and a potential selective pressure for biocide 74 
resistant populations of bacteria (10). Current clinical trial data has highlighted the limited 75 
antimicrobial efficacy of silver-impregnated catheters when compared to those without an 76 
antimicrobial coating, whilst nitrofurazone-containing coatings have been shown to exhibit 77 
only short-term antimicrobial activity and may therefore be ineffective in patients undergoing 78 
long-term catheterisation (11, 12). This has fuelled the search for further anti-infective 79 
coating agents that display broad-spectrum activity which is maintained after prolonged use. 80 
Long-term exposure of certain bacterial species to biocides may cause the induction of 81 
biocide insusceptibility either through the selection of intrinsically resistant mutants or 82 
through induced phenotypic adaptations, bringing into question the long-term antimicrobial 83 
activity of various biocide containing coatings (13). Concerns have also been raised that long-84 
term biocide exposure may promote cross-resistance to antibiotics through the acquisition of 85 
mutations in shared target sites or through the activation of broad-range defence mechanisms 86 
(14), such as increased cellular efflux activity (15) or decreased cell permeability (16).  It can, 87 
however, be argued that whilst long-term biocide exposure may lead to reductions in biocide 88 
or antibiotic susceptibility in bacteria, these reductions are small and would not impact on the 89 
susceptibility of bacteria to the concentrations of biocide used in practice. Furthermore, such 90 
changes in biocide susceptibility may be accompanied with functional deficits impacting 91 
biofilm formation, pathogenicity and competitive fitness in bacteria (17). Therefore in order 92 
to develop an effective anti-infective catheter coating the multiple long-term effects of the 93 
biocide used within the coating must be taken into consideration. 94 
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 Whilst previous investigations have evaluated the impact of long-term biocide exposure on 95 
the antimicrobial susceptibility of many clinically relevant bacteria, there is no current 96 
investigation into the multiple phenotypic consequences that may occur due to long-term 97 
biocide exposure in UPEC. The current study therefore aims to quantify the effects of long-98 
term biocide exposure in eight UPEC isolates. The commonly used biocides PHMB, triclosan, 99 
BAC and silver nitrate were evaluated for their long-term antibacterial and anti-biofilm 100 
activity and their potential to induce antibiotic cross-resistance. The impact that biocide 101 
exposure has on bacterial relative pathogenicity was assessed using a Galleria mellonella 102 
waxworm model and the biocides antiseptic potential was determined via calculating 103 
cytotoxicity in an L929 murine fibroblast cell line allowing the determination of a 104 
biocompatibility index value (18).  105 
Methods 106 
 Bacteria and chemicals. Six UPEC clinical isolates (EC1, EC2, EC11, EC26, EC28 107 
and EC34) previously isolated from urinary tract infections (Stepping Hill Hospital, 108 
Stockport, UK) and two laboratory characterised UPEC strains EC958 and CFT073 were 109 
used in the investigation. Bacteria were cultured on Muller-Hinton agar (MHA; Oxoid, UK) 110 
and Muller-Hinton broth (MHB; Oxoid, UK) and incubated aerobically at 37 °C for 18 h, 111 
unless otherwise stated.  Biocides were formulated as follows: triclosan solubilised in 5% 112 
(v/v) ethanol. Polyhexamethylene biguanide (PHMB) (LONZA, Blackley, UK), 113 
benzalkonium chloride (BAC) and silver nitrate were prepared at 1 mg/ml in water and filter 114 
sterilised prior to use. All chemicals were purchased from Sigma–Aldrich (Poole, UK) unless 115 
otherwise stated. 116 
 Long-term exposure of bacteria to biocides. Bacteria were repeatedly exposed to 117 
biocides using an antimicrobial gradient plating system adapted from McBain et al (19).  In 118 
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 brief, 100 µl of a 5 × MBC concentration solution of biocide was added to an 8 x 8 mm well 119 
in the centre of a 90 mm agar plate. Bacterial pure cultures were radially inoculated in 120 
duplicate from the edge of the plate to the centre, prior to incubation for 2 days aerobically at 121 
37°C. Biomass from the inner edge of the annulus of bacterial growth representative of the 122 
highest biocide concentration at which growth could occur was removed and used to 123 
inoculate a new biocide containing plate, as outlined above. This process was repeated for 12 124 
passages. Control isolates passaged 12 times on biocide free media were also included. 125 
Bacteria were archived at -80 °C before and after biocide passage for subsequent testing. 126 
 Minimum inhibitory and minimum bactericidal concentration. Minimum 127 
inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were 128 
determined as described previously (17). In brief, 2 × 5 ml overnight cultures of test bacteria 129 
were prepared in MHB prior to overnight incubation (18-24 h) at 37ºC and 100 rpm. Cultures 130 
were diluted to an OD600 of 0.008 in 20 ml of sterile MHB to produce a bacterial inoculum for 131 
biocide susceptibility testing. Doubling dilutions (150 µl) of each test biocide were prepared 132 
in sterile MHB in a 96-well microtiter plate prior to addition of bacterial inoculum (150 µl).  133 
Plates were incubated overnight (18-24 h) at 37ºC and 100 rpm. The MIC was defined as the 134 
lowest concentration of biocide for which growth was completely inhibited (viewed as 135 
turbidity relative to a sterile negative control). To determine MBC aliquots (5 µl) were taken 136 
from the wells of the MIC plate and were spot plated onto Muller Hinton Agar (MHA) in 137 
triplicate. The plates were incubated statically for 18-24 h at 37ºC. The lowest test 138 
concentration for which visible bacterial growth was completely inhibited was deemed the 139 
MBC.  140 
 Minimum biofilm eradication concentration. Minimum biofilm eradication 141 
concentrations were determined using the Calgary biofilm device (CBD) as described 142 
previously (20).  Briefly, 2 × 5 ml overnight cultures of test bacteria were prepared in MHB 143 
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 and were incubated for 18-24 h at 37ºC and 100 rpm before being diluted to an OD600 of 144 
0.008 in MHB to create a bacterial inoculum for biofilm susceptibility testing. 100 μl of 145 
bacterial inoculum was added to each well of the CBD base, plates were incubated at 37ºC 146 
for 48 h to allow biofilm formation on the pegs. Doubling dilutions of biocides were prepared 147 
in sterile broth across a 96-well microtiter plate. Biofilms were exposed to antimicrobial 148 
compounds and incubated for 24 h at 37°C and 100 rpm. After incubation, the pegged lid was 149 
transferred to a 96-well plate containing 200 μl of sterile broth and was incubated for 24 h at 150 
37°C and 100 rpm. MBEC was defined as the lowest concentration of biocide for which re-151 
growth was completely inhibited (viewed as turbidity relative to a sterile negative control) 152 
indicating complete biofilm eradication.  153 
 Crystal violet bacterial attachment assay. 2 × 5 ml overnight cultures of test 154 
bacteria were diluted to an OD600 of 0.008 in MHB after incubation for 18-24h at 37º C and 155 
100 rpm. 150 µl of diluted overnight bacterial culture was added to the wells of a sterile 96-156 
well microtiter plate. Plates were incubated statically for 48 h at 37ºC. Media was removed 157 
from wells and replaced with 180 µl of crystal violet solution. The plate was left at room 158 
temperature for 30 minutes, crystal violet solution was decanted and the wells were rinsed 159 
with 3 × 200 µl of PBS prior to drying for 1 h at 37ºC. The remaining crystal violet was 160 
solubilised in 250 µl of 100% ethanol. The A600 of the solubilised crystal violet solution was 161 
determined and compared to a sterile MHB negative control. 162 
 Galleria mellonella pathogenicity assay. The pathogenesis model was adapted from 163 
that of Peleg et al (21). Final larval-stage G. mellonella (Live Foods Direct, Sheffield, UK) 164 
were stored in the dark at 4°C for up to 7 days, before randomly assigning 24 to each 165 
treatment group and incubating at 37°C for 30 min. Overnight suspensions of E. coli were 166 
pelleted via centrifugation at 13,000 rpm, washed twice in 1 ml of PBS and then diluted 167 
appropriately to achieve an OD600 of 0.1 (5 × 10
5
 - 8 × 10
5
 CFU/ml, as confirmed by colony 168 
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 counts on MHA). Aliquots of each suspension (5 µl) were injected into the hemocele of each 169 
larva via the last left proleg using a Hamilton syringe. Larvae were incubated in a petri dish at 170 
37°C and the number of surviving individuals was recorded daily. An untreated group and a 171 
group injected with sterile PBS were used as additional controls. The experiment was 172 
terminated when at least two individuals in a control group had died or after 7 days of 173 
incubation. Two independent bacterial replicates were used to inoculate 24 caterpillars (12 174 
per replicate) and significance in death rate was calculated using a log-rank reduction test 175 
(p≤0.01).  176 
 Biocompatibility index. Calculation of biocompatibility index (BI) was performed as 177 
described by Muller and Kramer (18). To determine cytotoxicity, Neutral Red (NR) (3-178 
amino- 7-dimethylamino-2-methylphenazine hydrochloride) assays and MTT [3-(4,5-179 
dimethylthiazol-2-yl)-2, 5-diphenyltetra-zolium bromide] assays were performed on an L929 180 
cell line to establish IC50.  Procedures for the NR assay and the MTT test have been described 181 
in detail elsewhere (18). The bacterial quantitative suspension tests were done in accordance 182 
with the guidelines for testing disinfectants and antiseptics of the European Committee for 183 
Standardization (22). Suspension tests were performed in the presence of serum to determine 184 
the rf value, defined as the concentration of biocide that achieved a reduction in bacterial load 185 
of at least 3log10 (99.9%). Suspension tests were conducted as follows, overnight bacterial 186 
cultures were diluted to 10
8
-10
9
 CFU/ml as determined by colony counts on MHA. 15 µl 187 
aliquots of inoculum were then transferred into 135 µl of biocide containing cell culture 188 
medium prior to incubation for 30 min at 37ºC.  For PHMB, BAC, and triclosan, the biocide 189 
was subsequently inactivated by transfer of 15 µl of the suspension into 135 µL of TSHC 190 
(3% (w/v) Tween 80, 3% (w/v) saponin, 0.1% (w/v) histidine and 0.1% (w/v) cysteine). 191 
Silver nitrate was inactivated using TLA-thio (3% [w/v] Tween 80, 0.3% lecithin from soy 192 
bean, 0.1% [w/v] histidine and 0.5% [w/v] sodium thiosulphate). After 30 min of inactivation, 193 
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 5 µl aliquots were spot plated onto MHA in triplicate. The plates were incubated statically for 194 
18-24 h at 37ºC and CFU/ml was determined. The lowest test concentration which achieved 195 
at least a 3log10 (99.9%) reduction in bacterial load was deemed the rf value. BI is calculated 196 
as IC50/rf for each combination of biocide and isolate and indicates the antiseptic potential of 197 
the test compound.  198 
 Antibiotic susceptibility. Bacterial susceptibility was determined for trimethoprim 199 
sulfamethoxazole (25 µg), nitrofurantoin (50 µg), ciprofloxacin (10 µg), and gentamicin (200 200 
µg). Antibiotic susceptibility tests were performed according to the standardized British 201 
Society for Antimicrobial Chemotherapy (BSAC) disc diffusion method for antimicrobial 202 
susceptibility testing (23). 203 
 Determination of mutation rate frequency. Mutation rate frequency was 204 
determined as described by Miller et al (24) In brief, 100 µl aliquots of diluted overnight 205 
culture obtained from single bacterial colonies were plated onto antibiotic free MHA plates 206 
and MHA plates containing 50µg/ml rifampicin in triplicate. Plates were incubated for 24h at 207 
37ºC prior to determination of viable count. Mutation frequencies were expressed as the 208 
number of resistant mutants recovered as a fraction of total viable bacteria. 209 
Results 210 
 Biocide susceptibility of UPEC in planktonic and biofilm states. MIC, MBC and 211 
MBECs were determined for all test isolates before (P0) and after repeated passage either in 212 
the absence (C12) or presence of a specific biocide (P12) (Tables 1-3). Change in biocide 213 
susceptibility after exposure was calculated as fold-change relative to the control (C12, Table 214 
S1). Data indicates both the frequency of susceptibility change (≥2 fold) and the average 215 
magnitude of susceptibility change for each biocide.  216 
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 In terms of MIC, after repeated biocide exposure there was a ≥2 fold increase in 4/8 isolates 217 
for BAC, 8/8 for silver nitrate and 8/8 for triclosan compared to the respective bacteria 218 
passaged in a biocide free environment (Table 1). In contrast 4/8 isolates showed a ≥2 fold 219 
decrease in MIC after exposure to PHMB. The average fold-change for MIC (C12 to P12) 220 
across the test panel of UPEC was 1.5 for BAC, 0.7 for PHMB, 2 for silver nitrate and 807.1 221 
for triclosan (Table S1). For MBC in the biocide exposed isolates (Table 2) there was a ≥2 222 
fold increase in 4/8 isolates after BAC exposure, 8/8 for silver nitrate and 5/8 for triclosan. In 223 
contrast 1 isolate showed a decrease in MBC after PHMB exposure. The average fold change 224 
in MBC after biocide exposure was 1.5 for BAC, 0.8 for PHMB, 3.8 for silver nitrate and 5.4 225 
for triclosan (Table S1). In terms of MBEC (Table 3), after repeated biocide exposure there 226 
was a ≥2 fold increase in 7/8 isolates for BAC, 8/8 for PHMB and 8/8 for triclosan. Silver 227 
nitrate exposure led to a 1 increase in MBEC and 1 decrease. The average fold change in 228 
MBEC after biocide exposure was 4.5 for BAC, 29.2 for PHMB, 832.7 for triclosan and 7.8 229 
for silver nitrate (Table S1). We observed a number of changes in MIC, MBC and MBEC 230 
after the passage of bacteria solely in a biocide free-environment when compared to the 231 
unpassaged parent isolate. We did not, however see any incidence of a control passaged 232 
isolate (C12) exhibiting a significantly higher MIC, MBC or MBEC (P<0.05) than the 233 
respective biocide passaged isolate (P12) with the exception of PHMB where the biocide 234 
exposed isolates frequently exhibited a lower MIC and MBC than the unexposed parent strain 235 
and the control passaged isolate subsequently matched the susceptibility of the parent strain.   236 
 The impact of biocide exposure on UPEC biofilm formation. Biofilm formation 237 
was determined via a crystal violet biofilm assay for each UPEC isolate before and after 238 
repeated biocide exposure and after passage in a biocide free media (Figure 1). Unexposed 239 
isolates displayed varying biofilm forming capabilities prior to biocide exposure with EC2 240 
showing the highest level of biofilm formation followed by 241 
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 EC1>CFT073>EC11>EC28>EC34>EC26 and EC958. When repeatedly exposed to triclosan, 242 
all isolates (with the exception of CFT073) demonstrated a significant (ANOVA p≤0.05) 243 
increase in biofilm formation relative to the respective control. All isolates demonstrated a 244 
significant increase in biofilm formation after BAC exposure with the exception of EC2. For 245 
PHMB and silver nitrate, EC1 showed a significant increase in biofilm formation after 246 
repeated exposure to either biocide. PHMB exposure also induced decreases in biofilm 247 
formation in EC2 and CFT073. Differences in biofilm formation were determined to be 248 
irrespective of growth rate as we did not observe any significant (ANOVA p<0.05) change in 249 
growth rate or overall growth productivity when in binary culture (Figure S1).   250 
 Relative pathogenicity of UPEC after long-term biocide exposure. A G. 251 
mellonella waxworm model was used to determine relative pathogenicity in UPEC isolates 252 
(Figure 2). Data indicate that prior to biocide exposure, EC2 was the least pathogenic and 253 
EC1 and EC958 were the most pathogenic isolates. PHMB exposure induced significantly 254 
(log-rank p≤0.05) decreased relative pathogenicity in 3/8 isolates (EC11, EC34 and EC958) 255 
and a significant increase in pathogenicity for EC2 when compared to the respective control 256 
isolate (C12). BAC exposure induced significantly decreased pathogenicity in 6/8 isolates 257 
(EC1, EC11, EC26, EC28, EC34 and EC958) and significantly increased pathogenicity in 258 
EC2. Silver nitrate was the only biocide to only induce significant increases in pathogenicity 259 
which occurred in 2/8 isolates (EC11 and EC28) and triclosan was the only biocide to induce 260 
only significant decreases in pathogenicity which occurred in 5/8 isolates (EC11, EC26, 261 
EC34, EC958 and CFT073).    262 
 Changes in antibiotic susceptibility after biocide exposure. Isolates were classed as 263 
resistant or sensitive to each antibiotic as defined by BSAC breakpoints (23). Antibiotic 264 
susceptibility was determined for UPEC isolates before and after exposure to each biocide 265 
(Table 4). Data indicate that PHMB exposure induced CFT073 to become resistant to 266 
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 trimethoprim sulfamethoxazole and EC26 to become resistant to gentamicin. Exposure to 267 
triclosan induced nitrofurantoin resistance in EC958 and ciprofloxacin resistance in EC2. 268 
Silver nitrate exposure induced EC2 to become resistant to ciprofloxacin as did BAC 269 
exposure. There were cases where isolates that were initially resistant to trimethoprim 270 
sulfamethoxazole became more susceptible after biocide exposure. This occurred in EC2 271 
after exposure to PHMB, BAC, or silver nitrate and in EC11 after exposure to triclosan or 272 
BAC. This was also observed in EC11 for ciprofloxacin after triclosan exposure and CFT073 273 
after BAC, triclosan or silver nitrate exposure.  274 
 Biocompatibility Index. Cytotoxicity data for the four biocides against an L929 cell 275 
line are shown in Table 5, rf values, indicating antimicrobial activity, and the corresponding 276 
BI values, highlighting the antiseptic potential of the compounds, are shown in Table 6. The 277 
order of cytotoxicity in relation to the biocide concentration was silver 278 
nitrate>PHMB>BAC>triclosan. The only isolate for which an rf value could be determined 279 
for silver nitrate was CFT073 as the rf values for the other isolates exceeded the maximum 280 
solubility of the biocide. Similarly, an rf value could not be determined in EC28 and CFT073 281 
for triclosan as the rf value was greater than the highest achievable test concentration. BI 282 
values for the eight isolates were averaged for each biocide and the final ranked order of BI 283 
was PHMB>triclosan>BAC>silver nitrate indicating the antiseptic potential of the biocides. 284 
 Mutation rate frequency in UPEC isolates. Mutation rate frequency was 285 
determined with regards to rifampicin resistance. We observed rifampicin resistant mutants 286 
from all UPEC isolates (Table 7). Mutation frequencies varied from 1.7 x 10
-8 
for CFT073 up 287 
to 3 x 10
-7
 for EC2 with an overall mutation frequency rank order of 288 
EC2>EC28>EC11>EC1>EC34>EC958>EC26>CFT073.  289 
Discussion 290 
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 The current investigation aimed to explore the phenotypic changes that occur in genetically 291 
mixed populations of UPEC as a result of long-term biocide exposure. Susceptibility of eight 292 
UPEC isolates to a panel of test biocides was determined in planktonic and biofilm states 293 
before and after long-term biocide exposure. Changes that biocide exposure had on biofilm 294 
formation, relative pathogenicity and antibiotic susceptibility were assessed. Furthermore, 295 
cytotoxicity and the corresponding BI values were determined for each biocide against an 296 
L929 murine fibroblast cell line indicating the antiseptic potential of the test agents.  297 
 Biocide exposure induces changes in antimicrobial susceptibility in planktonic 298 
UPEC. The data in this investigation highlights that long-term exposure to biocides may 299 
influence biocide susceptibility in UPEC. Bacterial susceptibility to biocides can be markedly 300 
affected by structural variations in the bacterial cell that (i) impact attraction of the biocide to 301 
the cell (16) (ii) lead to changes in cell permeability to the biocide (25) and (iii) cause 302 
modification in efflux activity allowing the bacteria to expel the biocide from the cell (26). 303 
These modifications may account for some of the changes in biocide susceptibility observed 304 
in the current study, however the exact mechanisms that govern each specific adaptation 305 
depends upon a multitude of factors inherent to both the particular biocide and the bacterium 306 
(16). Furthermore, previous studies have indicated that biocide exposure in bacteria may 307 
result in reversible phenotypic adaptations that occur as a consequence of temporary changes 308 
in gene expression, for instance the induction of stress responses (27). In contrast, other 309 
investigations highlight that biocide exposure may lead to the selection of biocide resistant 310 
mutants with stable phenotypes that do not revert in the absence of the biocide (28). This may 311 
reflect diversity within the mechanisms of action of biocides particularly with regards to 312 
target site specificity. Bacterial exposure to target site specific biocides such as triclosan 313 
readily appears to lead to the selection of mutations in target enzyme FabI (28) whilst 314 
induced insusceptibility towards membrane active compounds such as biguanides (PHMB) 315 
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 and quaternary ammonium compounds (BAC)  is often associated with the induction of stress 316 
responses (29, 30). 317 
In terms of initial antimicrobial efficacy, silver nitrate demonstrated the lowest activity 318 
against planktonic UPEC when compared to other test biocides at MIC and MBC. We 319 
observed a high frequency of small magnitude decreases (≤2-fold) in silver nitrate 320 
susceptibility after long-term exposure resulting in comparatively high MIC and MBC values.  321 
Silver is widely considered as an effective anti-infective urinary catheter coating agent and is 322 
used in currently marketed anti-infective urinary catheters (31). However, previous 323 
investigations have also documented the selection of silver resistance in Gram negative 324 
pathogens (32) including E. coli and other invasive Enterobacteriaceae (33). This resistance 325 
has been correlated to increased efflux activity (34) or a loss of outer membrane porins (35) 326 
thereby decreasing cell permeability, which may explain the induced reductions in silver 327 
nitrate susceptibility observed in our UPEC isolates.  328 
PHMB exposure induced a high frequency of small magnitude (≤2-fold) increases in 329 
susceptibility in planktonic UPEC at MIC and MBC. Previous data indicate that changes in 330 
bacterial susceptibility in response to membrane active compounds, such as biguanides, is 331 
usually attributed to alterations in the structural integrity of the bacterial cell envelope 332 
impacting cell permeability, modifications in the structure of LPS interfering in electrostatic 333 
interactions between the cationic biocide and cell envelope and due to increased cellular 334 
efflux activity, expelling the biocide from the cell (27), these mechanisms of resistance are in 335 
contrast with the data in the current investigation. Whilst other studies have also highlighted 336 
increases in PHMB susceptibility in bacteria after long-term exposure the underlying 337 
mechanisms that govern this adaptation remains unknown. It has been suggested that long-338 
term exposure to certain biocides in bacteria may result in cumulative cellular damage and a 339 
resulting loss of fitness increasing bacterial susceptibility over time (13). The potential for 340 
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 PHMB to lead to increased susceptibility in bacteria after long-term exposure is an attractive 341 
attribute when considering an antimicrobial catheter coating agent, particularly in catheters  342 
that would be required for longer term use and are therefore prone to the selection of resistant 343 
microorganisms. 344 
Triclosan was the most potent antimicrobial before repeated biocide exposure in planktonic 345 
UPEC. However triclosan induced the largest frequency and magnitude of susceptibility 346 
decreases in MIC and MBC. Resistance of E. coli to triclosan has been widely documented 347 
and is believed to be due to a mutation in the target enzyme FabI (28), due to increased 348 
cellular efflux (15) and changes in the cell membrane composition that reduce permeability 349 
(36). Triclosan-impregnated catheters have demonstrated marked efficacy in in vitro studies 350 
(37), and show little reduction in antimicrobial activity even after long-term use (38). This 351 
may be due to the fact that whilst large susceptibility changes may occur in bacteria 352 
following triclosan exposure, as indicated in our data, the initial potency of triclosan means 353 
that the catheter maintains a high level of antimicrobial activity even after the bacteria adapt 354 
to the presence of the biocide likely due to its multi-target site mode of action.  355 
BAC demonstrated lower initial antimicrobial activity against planktonic UPEC compared to 356 
triclosan and PHMB (MIC and MBC) and only induced minor reductions (≤2-fold) in 357 
susceptibility after long-term exposure. Changes in gene expression in BAC adapted E. coli 358 
have been previously identified revealing an upregulation of efflux pump membrane 359 
transporter yhiV and downregulation of the outer membrane porin ompA thereby increasing 360 
cellular efflux of BAC and reducing cell permeability towards the biocide (39).  361 
Repeated passage of bacteria on a biocide free media occasionally led to changes in biocide 362 
susceptibility within planktonic culture, however these changes occurred at a substantially 363 
lower magnitude and frequency than those observed after biocide adaptation and were 364 
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 predominantly increases in susceptibility. This potentially emphasises the fitness costs 365 
associated with repeated culture. Significantly, we did not see any reduction in biocide 366 
susceptibility when comparing the isolate passaged in the absence of biocide to the 367 
unexposed parent strain.   368 
Biofilm formation and susceptibility in UPEC after biocide exposure. Bacteria 369 
that have adapted to the presence of biocides may exhibit further phenotypic alterations such 370 
as changes in growth rate, biofilm formation and competitive fitness, which may influence 371 
pathogenicity (13, 17). After biocide exposure several UPEC isolates in the current study 372 
exhibited significant changes in biofilm formation. Whilst this biofilm formation is a 373 
complex multifactorial process, these changes could potentially be attributed to the selection 374 
of mutants with alterations in factors involved in the establishment of biofilms, such as 375 
adhesion, EPS production or maturation.  376 
Biocide exposure largely led to increases in biofilm formation particularly after exposure to 377 
BAC and triclosan. Of the 7 UPEC isolates that demonstrated an increase in biofilm 378 
formation after BAC exposure 6 had a corresponding increase in MBEC. All 7 isolates that 379 
increased in biofilm formation after triclosan exposure also exhibited an elevation in MBEC. 380 
PHMB exposure led to a significant decrease in biofilm formation for EC2 and CFT073 381 
which did not correspond with decreases in MBEC, possibly indicating the recalcitrance of 382 
persister populations within the biofilm irrespective of biofilm biomass (40).  383 
BAC adaptation has been previously correlated to an increase in biofilm biomass in E. coli 384 
which is believed to be due to an increase in protein and polysaccharide content within the 385 
extracellular polymeric substance (EPS) (41). This change in EPS composition may lead to 386 
reduced BAC susceptibility, as observed in our BAC adapted isolates. Yu et al. (42) utilised a 387 
genome-wide enrichment screen to demonstrate the genes involved in triclosan adaptation in 388 
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 E. coli. Microarray analysis revealed that triclosan exposure resulted in an increase in 389 
fimDFHI which encodes proteins involved in fimbrial biosynthesis, that have been shown to 390 
be positively associated with an increase in biofilm formation (43).  This may provide a 391 
potential link between the increase in biofilm formation and thus resistance caused by 392 
triclosan exposure in the UPEC isolates used in the current investigation.  393 
               Changes in antibiotic susceptibility after biocide exposure in UPEC. Concerns 394 
have been raised that biocide exposure may induce cross-resistance to clinically relevant 395 
antibiotics. In the current study we observed the generation of antibiotic resistance in 6 out of 396 
a possible 84 combinations of bacteria, biocide and antibiotic. The biocides that induced the 397 
highest number of cases of cross-resistance in a previously susceptible or intermediate isolate 398 
were triclosan, which was to nitrofurantoin and ciprofloxacin, and PHMB which was to 399 
trimethoprim sulfamethoxazole and ciprofloxacin. BAC and silver nitrate exposure led to one 400 
observed case of cross-resistance each which was towards ciprofloxacin.  401 
There have been previous reports into efflux mediated cross-resistance between antibiotics 402 
and to triclosan reportedly due to upregulation of acrAB, encoding the AcrAB efflux pump 403 
(44). Efflux pumps have also been correlated to observed cross-resistance to between 404 
quaternary ammonium compounds and antibiotics in E. coli. Bore et al observed reduced 405 
antibiotic susceptibility in BAC-adapted E. coli which also coincided with an increase in the 406 
expression of acrAB and a downregulation in multiple outer membrane porins including 407 
OmpA, OmpF and OmpT (39). Whilst there is relatively sparse evidence on the generation of 408 
antibiotic cross-resistance due to PHMB exposure in bacteria, the mechanisms of uptake of 409 
PHMB is similar to that of aminoglycosides involving destabilisation of the bacterial cell 410 
membrane and LPS reorganisation (45). Interaction between LPS and PHMB is known to be 411 
a key step in the initial interaction of the biocide with the bacterial cell in E. coli (31). This 412 
may suggest why an induced reduction in PHMB susceptibility in our UPEC isolates also led 413 
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 to a similar reduction in susceptibility towards gentamicin. Studies on silver resistance in E. 414 
coli have revealed acquired low-level cross-resistance to cephalosporins, similarly due to 415 
increased efflux and reduced porin expression (35).  In this study, there were 9 cases of 416 
biocide exposure eliciting increased susceptibility trimethoprim sulfamethoxazole or 417 
ciprofloxacin. This occurred in 3 isolates after exposure to BAC or PHMB, in 2 isolates after 418 
silver nitrate exposure and in 1 isolate after PHMB exposure. This display of "cross-419 
protection" has been noted in previous studies and has been suggested to be due to a potential 420 
increase in cell permeability in response to biocide adaptation however the underlying 421 
mechanisms remain unclear (17). An increase in susceptibility to clinically relevant 422 
antibiotics in previously resistant uropathogens would be an extremely beneficial attribute 423 
when considering a coating agent to combat the establishment of CAUTI. 424 
 Biocompatibility of test biocides in an L929 cell line. To assess the suitability of an 425 
antiseptic agent both the antimicrobial activity and cytotoxicity must be considered. Silver 426 
nitrate showed the highest level of cytotoxicity in an L929 cell line and the lowest 427 
antimicrobial efficacy in the corresponding quantitative suspension test (rf value). Reduced 428 
activity of silver when in the presence of serum has been previously attributed to binding of 429 
the silver cations to the electronegative serum components, which may explain the low level 430 
of antimicrobial activity in silver nitrate observed in the quantitative suspension test in the 431 
current study (46). Silver ions have been demonstrated to interact with components of 432 
mammalian cells including the mitochondria, nuclei, endoplasmic reticulum and the cell 433 
membrane (47). Interaction of silver ions with mitochondria reportedly causes mitochondrial 434 
damage and the release of reactive oxygen species (ROS) resulting in apoptosis suggesting a 435 
mechanism of silver-mediated cytotoxicity (48). Whilst PHMB was shown to be the second 436 
most cytotoxic biocide tested, it exhibited a relatively low rf value resulting in the highest BI 437 
value out of all the test biocides. PHMB has previously shown low level cytotoxicity towards 438 
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 mammalian cells, including L929 cells, which is suggested to be due to the interaction of the 439 
biocide with the mammalian cell membrane leading to membrane damage (49). BAC was the 440 
second least cytotoxic biocide tested and the showed the second highest level of antimicrobial 441 
activity in the presence of serum in the quantitative suspension tests. BAC has been shown to 442 
interact with guanine nucleotide triphosphate-binding proteins (G proteins) impacting cell 443 
signalling transduction in mammalian cells and causing DNA damage (50). Cytotoxicity data 444 
indicated triclosan to be the least cytotoxic of all the test biocides. However the rf values 445 
were high resulting in the second highest BI value. Triclosan has previously shown reduced 446 
antimicrobial efficacy in the presence of serum, this is believed to be due to the bacteria’s 447 
ability to gain an exogenous supply of fatty acids from the serum, thereby bypassing the 448 
inhibitory effects of the biocide (51). Additionally, previous studies report on triclosan 449 
interference with mitochondrial respiration (52) in addition a damaging effect on the plasma 450 
membrane and induced apoptotic cell death (53) suggesting a potential mechanism of 451 
cytotoxicity.  452 
 Altered relative pathogenicity in biocide adapted UPEC. Repeated biocide 453 
exposure to silver nitrate induced an increase in relative pathogenicity in 2/8 isolates of 454 
UPEC whilst PHMB exposed isolates exhibited a decrease in pathogenicity in 3/8 and an 455 
increase in pathogenicity in 1/8 isolates respectively. A decrease in pathogenicity was 456 
observed after triclosan exposure in 5/8 isolates and in 6/8 isolates after exposure to BAC. 457 
BAC also induced an increase in pathogenicity in 1 further isolate. Triclosan exposure has 458 
previously been shown to reduce relative pathogenicity in a G. mellonella waxworm model in 459 
certain bacterial species (54). These pathogenicity changes were suggested to be due to 460 
changes in virulence factor production, specifically reduced DNase activity and a down-461 
regulation in cell surface adhesins (55). It has been shown that triclosan exposure specifically 462 
downregulates genes encoding the outer membrane proteins P-fimbriae and protein X in E. 463 
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 coli (56) which are integral for UPEC attachment to cell surfaces (57) and entry into host 464 
cells (58). Isolates of E. coli that have been exposed to BAC have been shown to have 465 
increased hemolysin activity and enhanced virulence (59) which may explain the increase in 466 
pathogenicity in EC2 after BAC exposure. To our knowledge there are no current studies 467 
regarding the effects of silver or PHMB exposure on bacterial virulence factor production and 468 
resulting pathogenicity. 469 
 Consequence of variance in mutation rate frequency in UPEC. Elevated mutation 470 
rates have been previously reported in E. coli strains (60). Furthermore, the adapting 471 
populations generated in the current investigation may lead to the selection of hypermutators 472 
due to the selective pressures created during biocide exposure. We evaluated the mutation 473 
frequencies in our parent isolates to determine whether this correlated to a higher frequency 474 
of phenotypic adaptations after biocide exposure. Mutation rate frequency was determined to 475 
be ordered EC2>EC28>EC11>EC1>EC34>EC958>EC26>CFT072. When comparing 476 
mutation rate to incidences of biocide susceptibility change (MIC, MBC and MBEC) EC11 477 
and CFT073 showed the highest frequency of changes in biocide susceptibility whilst EC28 478 
showed the least. We observed two cases of significant change in biofilm formation for each 479 
isolate with the exception of EC1 for which we observed four. In terms of significant changes 480 
in relative pathogenicity, EC11 demonstrated four significant changes after biocide exposure, 481 
EC34 and EC958 showed three, EC2, EC26 and EC28 showed 2 and EC1 and CFT073 482 
showed one. With regards to changes in antibiotic susceptibility, we saw the highest number 483 
of incidences of cross-resistance towards EC2.  These data indicate a potential correlation 484 
when comparing mutation rate frequency and antibiotic cross-resistance in UPEC but this 485 
trend does not extend to all aspects of phenotypic adaptation that occur as a result of biocide 486 
exposure.  487 
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  Conclusion. The use of biocides for the purpose of antisepsis has led to concern over 488 
the selection of biocide resistance in clinically relevant pathogens. Here we demonstrate that 489 
long-term exposure of UPEC to commonly used biocides can result in changes in biocide 490 
susceptibility which may be accompanied by further phenotypic alterations impacting biofilm 491 
formation, antibiotic susceptibility and relative pathogenicity. The multiple consequences of 492 
bacterial adaptation towards biocides should therefore be evaluated when considering a 493 
potential anti-infective catheter coating agent. 494 
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 Figure 1: Biofilm formation in biocide adapted UPEC 667 
 668 
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 Figure 1: Crystal violet biofilm assay indicating the effect of previous biocide exposure on 669 
biofilm formation in eight isolates of UPEC. Data shows the mean absorbance (A600) 670 
representative of biofilm formation for individual bacteria before and after long-term 671 
exposure to PHMB, triclosan, BAC or silver nitrate or after passage on a biocide free media 672 
(Control). Data represent samples taken from two separate experiments each with four 673 
technical replicates. For data that varied between replicates, SDs are given as error bars. 674 
Significance was determined using ANOVA; * p≤0.05.675 
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 Figure 2: Relative pathogenicity of biocide adapted UPEC 676 
Figure 2: G. mellonella survival curves for larvae injected with unexposed and biocide-677 
exposed  UPEC. Data represents 24 biological replicates. Data from non-injected larvae, 678 
larvae injected with PBS alone, and larvae injected with control isolates passaged on a 679 
biocide free media (Control; C12) are also shown. * indicates a significant difference in 680 
pathogenicity when comparing biocide adapted isolates to the respective control strain 681 
(p≤0.05, log-rank reduction test). 682 
 683 
 684 
 685 
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 Table 1: Minimum inhibitory concentrations for UPEC before and after biocide exposure. 686 
Minimum inhibitory concentrations (μg/ml) for UPEC before exposure to biocide (P0), after 687 
12 passages in the presence of each biocide (P12), and after 12 passages in a biocide free 688 
environment (C12). Data represent mean MICs taken from two separate experiments each 689 
with four technical replicates.  690 
  
PHMB 
 
Triclosan 
 
BAC 
 
Silver Nitrate 
 
 
Isolate 
 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
EC1 0.5 0.2 
 
0.5 0.00001 2 
 
0.02 (0.01) 15.6 15.6 
 
15.6 31.3 62.5 
 
31.3 
EC2 0.2 0.2 0.2 0.1 15.6 0.05 (0.02) 15.6 31.3 15.6 31.3 62.5 31.3 
EC11 0.2 0.2 0.2 0.1 2 0.05 (0.02) 15.6 31.3 15.6 31.3 62.5 31.3 
EC26 0.5 0.2 0.5 0.2 125 0.03 15.6 31.3 15.6 31.3 62.5 31.3 
EC28 0.5 0.5 0.5 0.2 3.9 0.2 (0.06) 15.6 15.6 15.6 31.3 62.5 31.3 
EC34 0.2 0.2 0.2 0.03 15.6 0.02 15.6 15.6 15.6 31.3 62.5 31.3 
EC958 1 0.2 1 0.1 7.8 0.03 15.6 31.3 15.6 31.3 62.5 31.3 
CFT073 
 
1 
 
0.2 
 
1 
 
0.1 
 
15.6 
 
0.02 
 
15.6 
 
15.6 
 
15.6 
 
31.3 
 
31.3 
 
15.6 
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 Table 2: Minimum bactericidal concentrations for UPEC before and after biocide exposure. 691 
Minimum bactericidal concentrations (μg/ml) for UPEC before exposure to biocide (P0), 692 
after 12 passages in the presence of each biocide (P12), and after 12 passages in a biocide 693 
free environment (C12). Data represent mean MBCs taken from two separate experiments 694 
each with four technical replicates.   695 
 696 
 697 
 698 
  699 
  
PHMB 
 
Triclosan 
 
BAC 
 
Silver Nitrate 
 
 
Isolate 
 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
EC1 1 0.5 
 
0.7 (0.3) 0.002 7.8 
 
7.8 15.6 31.3 
 
15.6 31.3 62.5 
 
31.3 
EC2 1 0.5 1 7.8 31.3 7.8 31.3 31.3 15.6 31.3 62.5 31.3 
EC11 1 0.5 0.5 7.8 7.8 7.8 15.6 31.3 15.6 31.3 62.5 31.3 
EC26 0.5 0.5 0.5 7.8 125 7.8 62.5 31.3 15.6 31.3 62.5 31.3 
EC28 1 1 1 7.8 7.8 7.8 31.3 15.6 19.5 (8) 31.3 62.5 31.3 
EC34 1 0.5 0.7 (0.3) 7.8 62.5 7.8 15.6 15.6 15.6 31.3 62.5 31.3 
EC958 2 1 1.1 (0.5) 7.8 62.5 7.8 62.5 15.6 15.6 31.3 500 31.3 
CFT073 
 
15.6 
 
1 
 
1.1 (0.5) 
 
7.8 
 
31.3 
 
7.8 
 
15.6 
 
15.6 
 
15.6 
 
31.3 
 
31.3 
 
15.6 
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 Table 3: Minimum biofilm eradication concentrations for UPEC before and after biocide 700 
exposure. 701 
Minimum biofilm eradication concentrations (μg/ml) for UPEC before exposure to biocide 702 
(P0), after 12 passages in the presence of each biocide (P12), and after 12 passages in a 703 
biocide free environment (C12). Data represent mean MBECs taken from two separate 704 
experiments each with four technical replicates.  705 
  
PHMB 
 
Triclosan 
 
BAC 
 
Silver Nitrate 
 
 
Isolate 
 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
P0 
 
P12 
 
C12 
 
EC1 31.3 2000 
 
93.8 (36) 7.8 31.3 
 
0.5 250 500 
 
125 2000 3000 
 
3000 
EC2 31.3 2000 93.8 (36) 3.9 250 2 125 500 62.5 3000 3000 3000 
EC11 31.3 250 7.8 2 125 0.06 125 125 13.7 (4) 3000 3000 54.7 (16) 
EC26 31.3 500 78.1 (31) 1 5000 2 250 250 93.8 (36) 2500 3000 3000 
EC28 62.5 2000 62.5 3.9 125 7.8 125 125 125 4000 3000 2750 (500) 
EC34 15.6 500 7.8 1 250 0.2 (0.07) 62.5 62.5 11.7 (5) 3000 3000 1750 (975) 
EC958 62.5 1000 23.5 (9) 7.8 125 1 250 250 62.5 4000 4000 3000 
CFT073 
 
31.3 
 
500 
 
35.2 (20) 
 
2 
 
500 
 
1 
 
62.5 
 
250 
 
62.5 
 
2000 
 
500 
 
1500 (577) 
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Antibiotic 
 
Exposure 
 
 
EC1 
 
EC2 
 
EC11 
 
EC26 
 
EC28 
 
EC34 
 
EC958 
 
CFT073 
T
ri
m
et
h
o
p
ri
m
 
S
u
lf
a
m
et
h
o
x
a
zo
le
  
Unexposed 
 
31.8 (1.3) S 
 
0 R 
 
0 R 
 
0 R 
 
0 R 
 
0 R 
 
0 R 
 
30 (0.6) S 
PHMB 31.7 (0.8) S 30.3 (0.6) S 0 R 0 R 0 R 0 R 0 R 0 R 
Triclosan 31.5 (0.6) S 0 R 32.3 (0.3) S 0 R 0 R 0 R 0 R 28.8 (0.4) S 
BAC 29.7 (3.6) S 26 S 31 (0.6) S 0 R 0 R 0 R 0 R 28.8 (1.3) S   
Silver Nitrate 32.7 (0.6) S 25.5 (0.5) S 0 R 0 R 0 R 0 R 0 R 29.5 (0.5) S 
N
it
ro
fu
ra
n
to
in
 
 
 
Unexposed 
 
20.3 (0.3) S 
 
20.7 (0.3) S 
 
23.7 (0.3) S 
 
21.2 (1.5) S 
 
19.7 (0.5) S 
 
16.3 (1.2) S 
 
20.4 (1.4) S 
 
18 (0.6) S 
PHMB 20.3 (0.9) S 19.5 (0.5) S 25 (1) S 23.2 (3.1) S 19.2 (0.4) S 15 (0.6) S 19.8 (0.25) S 17.8 (0.8) S 
Triclosan 20 (0.6) S 20.5 (0.6) S 24.7 (0.3) S 24.2 (1.5) S 18.7 (1.4) S 18 (0.6) S 0 R 21.2 (0.4) S 
BAC 19.3 (0.3) S 18.5 (0.5) S 23.8 (0.3) S 23.3 (3.1) S 19.5 (1.5) S 15.2 (1.2) S 20.4 (0.1) S 17.2 (0.4) S 
Silver Nitrate 20.3 (0.3) S 18.8 (0.3) S 23.5 (1.6) S 23.3 (2.1) S 21.3 (0.5) S 15.8 (0.8) S 20 S 17.2 (0.4) S 
 
C
ip
ro
fl
o
x
a
ci
n
 
 
 
Unexposed 
 
31.2 (0.8) S 
 
34 (0.6) S 
 
13.8 (0.6) R 
 
0 R 
 
30 S 
 
0 R 
 
0 R 
 
0 R 
PHMB 31.3 (0.8) S 35 (0.6) S 0 R 0 R 30 S 0 R 0 R 0 R 
Triclosan 32.5 (0.5) S 0 R 29.5 (0.8) S 0 R 30.7 (1) S 0 R 0 R 33.2 (1.9) S 
BAC 30 (0.3) S 0 R 0 R 0 R 29.7 (0.8) S 0 R 0 R 31.2 (1.8) S 
Silver Nitrate 31.2 (0.3) S 0 R 0 R 0 R 29.7 (0.8) S 0 R 0 R 31.7 (2.1) S 
 
G
en
ta
m
ic
in
 
 
 
Unexposed 
 
26 (0.5) S 
 
27.7 (0.3) S 
 
25.5 (0.6) S 
 
14.3 (1.2) I 
 
18.2 (1) S 
 
16.5 (0.5) I 
 
26 S 
 
24.8 (0.4) S 
PHMB 25.5 (0.6) S 28.1 (0.4) S 27.3 (0.3) S 11.8 (0.8) R 18.5 (1.6) S 16.2 (1.2) I 26.4 (0.5) S 25 S 
Triclosan 25.8 (0.3) S 16 I 23.5 (0.6) S 15.8 (3.5) I 20.8 (1) S 20 (0.9) S 27 (0.6) S 28.3 (1.4) S 
BAC 26.5 (0.5) S 25.8 (0.8) S 25.3 (0.3) S 16.8 (0.8) I 18.8 (0.8) S 18 S 26.7 (0.6) S 24.7 (0.5) S 
Silver Nitrate 27.8 (0.3) S 27.2 (0.1) S 27 (0.3) S 15.2 (1.5) I 18.7 (0.8) S 17 (1.3) S 26.2 (0.3) S 24 S 
 
Table 4: Antibiotic susceptibility of UPEC before and after biocide exposure 
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 Data show the mean antibiotic inhibition zones (mm) for UPEC before and after biocide exposure (mm) and represent samples taken from two 706 
separate experiments each with three technical replicates. For data that varied between replicates, SDs are given in parentheses. S = Sensitive, I 707 
= Intermediate, R = Resistant, as defined by BSAC breakpoint (23).708 
Figure 1: Survival curves showing virulence of eight UPEC strains and the effect of biocide exposure  
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 Table 5: Biocide cytotoxicity in an L929 murine fibroblast cell line 709 
Mean concentration of biocides allowing 50% survival (IC50) of murine fibroblasts after 30 710 
min at 37ºC as determined via NR and MTT assays. Mean IC50 based on mass and molecular 711 
weight (m.w.). Data indicates two separate experiments each with six replicates.  712 
 
Biocide 
 
NR IC50  
 
MTT IC50  
 
m.w. 
 
 
           Mean IC50 
 
 
 
PHMB 
 
0.02  
 
0.03 
 
2800 
 
0.026 0.000009 
Triclosan 0.19  0.14  289.54 0.16 0.00057 
BAC 0.07  0.03  340 0.047 0.00014 
Silver Nitrate 0.002  0.003  169.87 0.0027 0.000016 
 
mg/ ml                  mmol/ ml 
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  Table 6: Concentration of biocide producing 3 log10 reduction (rf) on eight isolates of UPEC determined by quantitative suspension test and the 713 
resulting BI 714 
Data shows the concentration of biocide (mg/l) producing 3 log10 reduction (rf) after 30 min of exposure at 37ºC on eight isolates of UPEC and 715 
the resulting BI value. NC- not calculable, for certain combination of biocide and bacterial isolate the rf value exceeded the maximum solubility 716 
of the biocide. Data represent mean rf  values taken from two separate experiments each with four technical replicates. 717 
 
Biocide 
 
 
EC1 
 
 
EC2 
 
EC11 
 
EC26 
 
EC28 
 
EC34 
 
EC958 
 
CFT073 
  
rf  
 
BI 
 
rf  
 
BI 
 
rf  
 
BI 
 
rf  
 
BI 
 
rf  
 
BI 
 
rf  
 
BI 
 
rf  
 
BI 
 
rf  
 
BI 
 
 
 
PHMB  
 
0.02 
 
1.6 
 
0.06 
 
0.4 
 
0.01 
 
1.6 
 
0.02 
 
1.6 
 
0.3 
 
0.1 
 
0.1 
 
0.2 
 
0.5 
 
0.05 
 
0.02 
 
1.6 
 
Triclosan 
 
 
0.2 
 
0.7 
 
1.1 
 
0.1 
 
0.2 
 
0.7 
 
1.1 
 
0.1 
 
NC 
 
NC 
 
0.6 
 
0.3 
 
2.3 
 
0.07 
 
NC 
 
NC 
BAC 
 
0.07 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.6 0.08 0.07 0.7 
Silver 
Nitrate 
 
NC NC NC NC NC NC NC NC NC NC NC NC NC NC 0.01 0.2 
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 Table 7: Mutation rate frequencies for unexposed UPEC 718 
 
Isolate 
 
 
Mutation Rate  
 
EC1 8 (1.7)  x 10-8 
EC2 3 (1) x 10-7 
EC11 1.4 (0.4) x 10-7 
EC26 3.4 (0.3) x 10-8 
EC28 1.9 x (1) x 10-7 
EC34 6.8 (5.4) x 10-8 
EC958 3.5 (2.3) x 10-8 
CFT073 1.7 (1) x 10-8 
  
 719 
Mutation rate frequencies in UPEC isolates resulting in rifampicin resistance, standard deviations are shown in the parenthesis (n=3).  720 
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